Evaluation of Functionalized Biopolymers as a Step Toward Targeted Therapy of Osteoporosis

Evaluation of Functionalized Biopolymers as a Step Toward Targeted Therapy of Osteoporosis

The work presented in this thesis focuses on the development of strategies and smart bioactive materials for the treatment of osteoporosis. High and low molecular weight soluble hyaluronic acid-bisphosphonate (HA-BP) derivatives were investigated for their ability to inhibit osteoclasts. Low molecul...

Full description

Bibliographic Details
Main Author:	Kootala, Sujit
Format:	Doctoral Thesis
Language:	English
Published:	Uppsala universitet, Polymerkemi 2015
Subjects:	Osteoporosis Bone regeneration Biomaterials Hyaluronic acid Bisphosphonates Osteoclasts Osteoblasts Growth factors
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-259386 http://nbn-resolving.de/urn:isbn:978-91-554-9287-8

Similar Items

The Influence of Strontium on Bone Tissue Metabolism and Its Application in Osteoporosis Treatment
by: Barbara Kołodziejska, et al.
Published: (2021-06-01)

POSTMENOPAUSAL OSTEOPOROSIS – AN EXPLORATIVE LITERATURE REVIEW
by: Iulian Ștefan HOLUBIAC, et al.
Published: (2019-12-01)

Cellular Mechanisms Responsible for Success and Failure of Bone Substitute Materials
by: Tim Rolvien, et al.
Published: (2018-09-01)

Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation
by: Yoon-Hee Cheon, et al.
Published: (2021-07-01)

The Development of Molecular Biology of Osteoporosis
by: Yongguang Gao, et al.
Published: (2021-07-01)

Osteoporosis: From Molecular Mechanisms to Therapies
by: Chih-Hsin Tang
Published: (2020-01-01)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
by: Cheng-Huan Peng, et al.
Published: (2021-01-01)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
by: Sheng Zhu, et al.
Published: (2021-12-01)

Magnesium and Osteoporosis: Current State of Knowledge and Future Research Directions
by: Jeanette A. M. Maier, et al.
Published: (2013-07-01)

Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review
by: Yuichiro Ukon, et al.
Published: (2019-05-01)

Osteoprotective Effects of Loganic Acid on Osteoblastic and Osteoclastic Cells and Osteoporosis-Induced Mice
by: Eunkuk Park, et al.
Published: (2021-12-01)

NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?
by: Na Jiang, et al.
Published: (2021-09-01)

Mechanisms of osteoporosis development in patients with rheumatoid arthritis
by: Agnieszka Matuszewska, et al.
Published: (2014-02-01)

Effects of Caffeic Acid and Its Derivatives on Bone: A Systematic Review
by: Ekeuku SO, et al.
Published: (2021-01-01)

Effects of lycopene on the skeletal system
by: Patrycja Sołtysiak, et al.
Published: (2015-02-01)

Target approach to treating osseous system pathology
by: M. B. Stenina, et al.
Published: (2014-08-01)

Live imaging of osteoclast inhibition by bisphosphonates in a medaka osteoporosis model
by: Tingsheng Yu, et al.
Published: (2016-02-01)

Long Non-coding RNAs: A New Regulatory Code for Osteoporosis
by: Qian-Yuan Wu, et al.
Published: (2018-10-01)

Tranexamic Acid Promotes Murine Bone Marrow-Derived Osteoblast Proliferation and Inhibits Osteoclast Formation In Vitro
by: Anke Baranowsky, et al.
Published: (2021-01-01)

Purinergic signalling in bone
by: Robin Mark Howard Rumney, et al.
Published: (2012-09-01)

Role of Cannabinoids in the Regulation of Bone Remodelling
by: Aymen I Idris, et al.
Published: (2012-11-01)

Bone Health and Natural Products- An Insight
by: Vasanti Suvarna, et al.
Published: (2018-09-01)

The Osteoprotective Effects Of Kaempferol: The Evidence From In Vivo And In Vitro Studies
by: Wong SK, et al.
Published: (2019-10-01)

The Dual Role of Oat Bran Water Extract in Bone Homeostasis Through the Regulation of Osteoclastogenesis and Osteoblast Differentiation
by: Shin-Hye Kim, et al.
Published: (2018-11-01)

Daily intake of β-cryptoxanthin prevents bone loss by preferential disturbance of osteoclastic activation in ovariectomized mice
by: Kakeru Ozaki, et al.
Published: (2015-09-01)

Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
by: Yeon-Suk Yang, et al.
Published: (2020-06-01)

Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p
by: Li, X., et al.
Published: (2022)

Nanoparticles for the treatment of osteoporosis
Published: (2017-03-01)

Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model
by: Huijuan Wang, et al.
Published: (2018-09-01)

The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma
by: Francesca Rossi, et al.
Published: (2019-04-01)

Nanohydroxyapatite (nHAp) Doped with Iron Oxide Nanoparticles (IO), miR-21 and miR-124 Under Magnetic Field Conditions Modulates Osteoblast Viability, Reduces Inflammation and Inhibits the Growth of Osteoclast – A Novel Concept for Osteoporosis Treatment: Part 1
by: Marycz K, et al.
Published: (2021-05-01)

The Effects of Tocotrienol on Bone Peptides in a Rat Model of Osteoporosis Induced by Metabolic Syndrome: The Possible Communication between Bone Cells
by: Sok Kuan Wong, et al.
Published: (2019-09-01)

STUDIES REGARDING THE IDENTIFICATION OF SOME HISTO-MORPHOLOGICAL PARAMETERS THAT COULD BE USED AS MARKERS FOR BONE MINERALIZATION APPRECISAL IN PIGS – SCIENTIFIC SUPPORT IN OSTEOPOROSIS STUDY
by: GABI DUMITRESCU, et al.
Published: (2007-05-01)

Osteoporosis Treatment with Anti-Sclerostin Antibodies—Mechanisms of Action and Clinical Application
by: Martina Rauner, et al.
Published: (2021-02-01)

Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence
by: Sok Kuan Wong, et al.
Published: (2020-09-01)

Petunidin, a B-ring 5′-<i>O</i>-Methylated Derivative of Delphinidin, Stimulates Osteoblastogenesis and Reduces sRANKL-Induced Bone Loss
by: Masahiro Nagaoka, et al.
Published: (2019-06-01)

Can telomere length predict bone health? A review of current evidence
by: Sok Kuan Wong, et al.
Published: (2020-03-01)

High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms
by: Chandi Charan Mandal
Published: (2015-10-01)

Aspalathin from Aspalathus linearis (rooibos) reduces osteoclast activity and increases osteoblast activity in vitro
by: Travers Sagar, et al.
Published: (2020-01-01)

Despite Genetic Iron Overload, Hfe‐Hemochromatosis Mice Do Not Show Bone Loss
by: Alessa Wagner, et al.
Published: (2019-09-01)